A multiple-dose crossover study of Patiromer in healthy subjects.

Trial Profile

A multiple-dose crossover study of Patiromer in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Dec 2016

At a glance

  • Drugs Patiromer (Primary)
  • Indications Hyperkalaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Dec 2016 New analyses of data from this and another phase I trial (CT profile 268635) were presented at the National Kidney Foundation (NKF) 2016 Spring Clinical Meeting, according to a Relypsa Inc. media release.
    • 28 Apr 2016 Results of new analyses from this and another phase I trial (CT profile 268635) published in a Relypsa Inc. media release.
    • 21 Apr 2016 According to Relypsa media release, data will be presented at National Kidney Foundation 2016 Spring Clinical Meetings.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top